Table 2.
Number of patients (%) | P value | ||||
---|---|---|---|---|---|
CCC (n = 17) | EC (n = 17) | HGSC (n = 51) | MC (n = 11) | ||
Patient age | 0.95 | ||||
Mean | 63 | 64 | 63 | 61 | |
Range | 42–84 | 25–83 | 32–86 | 39–80 | |
Overall Survival | 0.45 | ||||
0–2 y | 2 (12) | 1 (6) | 2 (4) | 3 (27) | |
2–5 y | 3 (18) | 5 (29) | 17 (33) | 2 (18) | |
5–10 y | 7 (41) | 5 (29) | 19 (37) | 3 (27) | |
>10 y | 5 (29) | 6 (35) | 13 (25) | 3 (27) | |
Cause of death | 0.01 | ||||
Ovarian carcinoma | 10 (59) | 3 (18) | 33 (65) | 2 (18) | |
Other cancer | 0 (0) | 3 (18) | 7 (14) | 3 (27) | |
Other | 6 (35) | 6 (35) | 5 (10) | 4 (36) | |
Not available | 1 (6) | 0 (0) | 0 (0) | 0 (0) | |
Alive | 0 (0) | 5 (29) | 6 (12) | 2 (18) | |
Stage | 0.15 | ||||
I | 14 (82) | 11 (65) | 29 (57) | 9 (82) | |
II | 3 (18) | 6 (35) | 22 (43) | 2 (18) | |
Tumor grade EC | NA | ||||
FIGO grade I | NA | 2 (12) | NA | NA | |
FIGO grade II | NA | 9 (53) | NA | NA | |
FIGO grade III | NA | 6 (35) | NA | NA | |
CA125 | 0.068 | ||||
<35 | 6 (35) | 7 (41) | 9 (18) | 5 (45) | |
35–65 | 1 (6) | 0 (0) | 29 (57) | 2 (18) | |
>65 | 10 (59) | 10 (59) | 13 (25) | 4 (36) | |
Not available | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
Ploidy | 0.095 | ||||
Near diploid | 1 (6) | 7 (41) | 15 (29) | 2 (18) | |
Aneuploid | 16 (94) | 9 (53) | 36 (71) | 8 (73) | |
Not available | 0 (0) | 1 (6) | 0 (0) | 1 (9) | |
Chemotherapy | NA | ||||
Yes | 17 (100) | 17 (100) | 49 (96) | 11 (100) | |
No | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
Not available | 0 (0) | 0 (0) | 2 (4) | 0 (0) |
Significant values (P value<0.05) are marked in bold.